Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$42,000.00
% of Total Estimate Gain
0.70%

Crossingbridge Advisors, LLC's Translational Development Acquisition Corp Holding Summary

As of 2025-03-31, Crossingbridge Advisors, LLC held - shares of Translational Development Acquisition Corp(TDACU), totaling N/A. This investment constitutes 0% of their stock portfolio, and Crossingbridge Advisors, LLC now holds -% of the outstanding Translational Development Acquisition Corp(TDACU) stock.

The initial trade took place in 2024Q4. And since then Crossingbridge Advisors, LLC has made 1 purchases of TDACU, at an average price of $10.02, for a total of 600,000.00 shares. In addition, there have been 1 sales at an average price of $10.09 for 600,000.00 shares. Based on historical transaction data and TDACU's current price of $10.43, Crossingbridge Advisors, LLC's estimated gain on his TDACU holdings is $42,000.00, reflecting a 0.70% gain to date.

Crossingbridge Advisors, LLC TDACU ($10.43) Holding Chart

Crossingbridge Advisors, LLC TDACU ($10.43) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1